Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

Rhea-AI Summary

Integra LifeSciences (Nasdaq: IART) will exhibit at the Congress of Neurological Surgeons Annual Meeting in Los Angeles from October 11–15, 2025. The company will showcase neurosurgical devices including Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit, Post, plus CereLink ICP Monitoring System, CUSA Clarity Tissue Ablation System, Aurora Surgiscope System, and Certas Plus Programmable Valve. Integra will be at booth #713 to engage neurosurgeons and demonstrate product features aimed at improving surgical visualization and dural repair.

Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post

PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce its exhibition at the CNS Annual Meeting, from October 11 through 15, 2025, in Los Angeles, California. The company’s booth will spotlight its industry-leading products, while featuring two recent additions to the portfolio - Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit, Post.

Durepair Dura Regeneration Matrix is a strong suturable graft¹ that complements Integra’s extensive portfolio of dural grafts and sealants, and the Mayfield Ghost device is engineered with minimal artifact materials to support clear visualization of anatomical structure for surgical procedures.

"CNS is an excellent opportunity for our team to connect with the neurosurgical community—experts who are just as passionate as we are about restoring patient lives,” said Mike McBreen, executive vice president and president, Codman Specialty Surgical. “The conference is also a great platform to showcase our latest innovations and demonstrate our dedication to advancing neurosurgical care through medical technologies.”

At CNS, Integra will be located at booth #713. Attendees can learn more about several of the company’s medical technologies, including the CereLink^® ICP Monitoring System, CUSA^® Clarity Tissue Ablation System, Aurora^® Surgiscope System, and the Certas^® Plus Programmable Valve.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership medical technology brands. For the latest news and information about Integra and its products, please visit www.integralife.com.

¹ Zerris et al. J of Biomed Mat Rsch 2007; 83B (2):580-588 (Canine Study)

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com

FAQ

When and where will Integra (IART) exhibit at the CNS Annual Meeting in 2025?

Integra will exhibit in Los Angeles at the CNS Annual Meeting from October 11–15, 2025.

What Integra products will be highlighted at the CNS meeting (IART)?

Highlighted products include Durepair Dura Regeneration Matrix, Mayfield Ghost Base Unit, Post, CereLink ICP, CUSA Clarity, Aurora Surgiscope, and Certas Plus.

Where can attendees find Integra's booth at CNS 2025 (IART)?

Integra will be located at booth #713 during the CNS Annual Meeting.

What is Durepair Dura Regeneration Matrix showcased by Integra (IART)?

Durepair is presented as a strong, suturable dural graft designed to complement Integra's dural grafts and sealants portfolio.

What is the Mayfield Ghost Base Unit being presented by Integra (IART)?

The Mayfield Ghost Base Unit is engineered with minimal-artifact materials to support clearer surgical visualization of anatomy.

How can investors or clinicians learn more about Integra's CNS presentations (IART)?

Attendees can visit booth #713 at CNS to see demonstrations and speak with Integra representatives.